First-line treatment outcomes according to cfDNA analysis of RAS mutation status in metastatic colorectal cancer (mCRC) patients (pts): PERSEIDA study

  1. García Alfonso, P.
  2. Valladares-Ayerbes, M.
  3. Muñoz Luengo, J.
  4. Pimentel, P.
  5. Viéitez, J.M.
  6. Cruz Hernandez, J.J.
  7. Llanos, M.
  8. Garcia Girón, C.
  9. Salud Salvia, A.
  10. Lloansí Vila, A.
Aldizkaria:
Annals of oncology : official journal of the European Society for Medical Oncology

ISSN: 1569-8041

Argitalpen urtea: 2018

Alea: 29

Orrialdeak: viii183

Mota: Artikulua

DOI: 10.1093/ANNONC/MDY281.092 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus